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INTRODUCTION
Vitamin D, a fat-soluble steroid hormone, is important for
calcium and phosphorus homeostasis and musculoskeletal
health. In children, severe vitamin D deficiency manifests as
rickets, and vitamin D inadequacy can impair attainment of
peak bone mass. In adults, inadequate vitamin D can result
in secondary hyperparathyroidism, decreased bone mineral
density, osteomalacia, and increased risk of fragility fractures
(1). Moreover, inadequate vitamin D may be involved in the
pathogenesis and/or progression of several disorders, includ-
ing cancer, hypertension, osteoarthritis, diabetes, and other
autoimmune diseases (1-6). 
Infants between 4 months and 2 yr of age are at a high risk
for the relative vitamin D deficiency because of their rapid
growth in skeletal system. The incidence of vitamin D defi-
ciency during infancy had been decreased in the past with
the improvement of nutritional condition such as vitamin D
supplementation in infant formula. But, lately it has been
increased again for various reasons such as breast-feeding from
vitamin D deficient mother, lack of sun-light exposure (cos-
metic or dermatologic reasons, sun-block, etc.), high latitude,
dark skin, and low dietary intake of vitamin D, etc. (7-10).
In response to the resurgence of rickets especially in breast-
fed infants, the American Academy of Pediatrics revised its
policy on vitamin D supplementation to infants and children
in 2003 (11). 
The incidence of vitamin D deficiency would be high as
well in Korean infants for similar reasons, but there are few
clinical studies performed to evaluate the nutritional status
of vitamin D during infancy. Therefore, in this study, we evalu-
ate the vitamin D status in Korean infants, and further deter-
mine the efficacy of vitamin D supplementation on the vita-
min D nutritional status and bone mineralization in term
breast-fed infants.
MATERIALS AND METHODS
Subjects and study design
This study was approved by the Institutional Review Board
of Chungbuk National University. And the informed consents
were obtained from mothers. The healthy term infants deliv-
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Nutritional Status of Vitamin D and the Effect of Vitamin D 
Supplementation in Korean Breast-fed Infants 
We investigated the vitamin D status and the effect of vitamin D supplementation
in Korean breast-fed infants. The healthy term newborns were divided into 3 groups;
A, formula-fed; B, breast-fed only; S, breast-fed with vitamin D supplementation. We
measured serum concentrations of vitamin D (25OHD3), calcium (Ca), phosphorus
(P), alkaline phosphatase (AP), intact parathyroid hormone (iPTH) and bone min-
eral density (BMD) at 6 and 12 months of age. Using questionnaires, average dura-
tion of sun-light exposure and dietary intake of vitamin D, Ca and P were obtained.
At 6 and 12 months of age, 25OHD3 was significantly higher in group S than in group
B (P<0.001). iPTH was significantly lower in group S than in group B at 6 months
(P=0.001), but did not differ at 12 months. Regardless of vitamin D supplementa-
tion, BMD was lower in group B and S than in group A (P<0.05). Total intake of vita-
min D differed among 3 groups (P<0.001, A>S>B), but total intake of Ca and P were
higher in group A than in group B and S (P<0.001). In conclusion, breast-fed infants
show lower vitamin D status and bone mineralization than formula-fed infants. Vita-
min D supplementation (200 IU/day) in breast-fed infants increases serum 25-OH
vitamin D3, but not bone mineral density.
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Accepted : 4 March 2009ered at Chungbuk National University Hospital from July
2004 through June 2005 were enrolled in this study. Study
infants were divided into 3 groups: A, formula-fed; B, breast-
fed only without supplementation; S, breast-fed with vitamin
D supplementation. During 1 yr follow-up period after en-
rollment, serum concentrations of vitamin D (25OHD3),
calcium (Ca), inorganic phosphorus (P), alkaline phosphatase
(AP), intact parathyroid hormone (iPTH), bone mineral den-
sity (BMD), and bone mineral content (BMC) were measured
at birth, 6 and 12 months of age. Average duration of sun-
light exposure (min/day) and total intake of vitamin D, Ca
and P were obtained by maternal interview using question-
naires. 
Vitamin D supplementation
In group S infants, 0.5 mL of Poly-Vitamin Drops
� (Hi-
Tech Pharmacal Co. Inc., Amityville, NY, USA) was given
once a day from 2 months of age till the end of this study.
Poly-Vitamin Drops
�, a multivitamin preparation, contains
vitamin A (1,500 IU/mL), vitamin D (400 IU/mL), vitamin
E (5 IU/mL), vitamin C (35 mg/mL), thiamin (0.5 mg/mL),
riboflavin (0.6 mg/mL), niacin (8 mg/mL), vitamin B6 (0.4
mg/mL), iron (10 mg/mL), and fluoride (0.25 mg/mL).
Biochemical analysis 
Serum samples were stored at -20℃ in light-proof bot-
tles before biochemical assay in the Green-Cross Laboratory,
Seoul, Korea. Serum 25OHD3 concentration was measured
by radioimmunoassay (25OH-VIT.D3-RIA-CA kit, Bio-
source, Europe; intra-assay and interassay coefficient of vari-
ation, 4.7 and 5.3, respectively) and intact PTH (iPTH) by
electrochemiluminescence (reference: 15-65 pg/dL). 
In this study, vitamin D deficiency, insufficiency, and suf-
ficiency were defined as serum 25OHD3 level less than 11
ng/mL, 11-30 ng/mL, and over 30 ng/mL, respectively (1, 4,
12, 13). 
Analysis of bone mineralization
Study infants at 6 and 12 months of age underwent the
measurement of lumbar-spine (L2-L4) bone mineral content
(BMC, g) and areal bone mineral density (BMD, g/cm2) by
dual-energy radiography absorptiometry (DXA) using the
Lunar Expert-XL DEX system (Lunar Corp., Madison, WI,
USA) or Norland XR-36 system (Norland Medical System,
Inc., Atkinson, WI, USA) according to the manufacturer’s
operator manuals. 
Survey: sun-light exposure and dietary intake 
The average duration of sun-light exposure per day (UV,
min/day) were derived from the minutes spent outside dur-
ing 3 days preceeding the visit. Dietary intake data were col-
lected using a 24-hr recall method at 6 and 12 months of age
to estimate the intakes of vitamin D, calcium, and phospho-
rus. Breast milk intake was estimated by multiplying the
nursing frequency and the average amount of milk per nurs-
ing which was measured in 6 month-old infants in a previous
study (14). The intake of each nutrient was calculated based
on the nutrient database in the 8th edition of Pediatrics (vita-
min D, 6 mg/L; calcium, 270 mg/L; phosphorus, 140 mg/L
of breast milk), the 7th Korean Recommended Dietary Al-
lowances (15), vitamin D composition published in Korea
Health Industry Development Institute (16), and the nutri-
tion label claimed by the manufacturers in formula using
DS24 WIN Program (nutrient analysis software developed
by Human Nutrition Lab. in Seoul National University) in
the Department of Food and Nutrition.
Statistical analysis
We assessed differences between groups using chi-square
test for categorical variables and t-test or ANOVA followed
by Duncan procedure for post-hoc test for continuous vari-
ables, as appropriate. P<0.05 was considered statistically sig-
nificant. 
RESULTS
Demographic data, lifestyle characteristics, and vitamin
D status of the study infants and mothers at birth
Total 74 newborns and their mothers were studied at birth,
among which 25, 28, and 21 infants belonged to the group A
(formula-fed), group B (breast-fed only), and group S (breast-
fed with vitamin D supplementation), respectively. 
About 60% of study infants were male, and their mean ges-
tational age, body weight, length, and head circumference
at birth were 276±9.0 days, 3.25±0.37 kg, 49.7±2.01
cm, and 34.0±1.37 cm, respectively. There were no differ-
ences among 3 study groups in demographic and lifestyle
characteristics such as maternal age, job, education and resi-
dence at the time of delivery. Study infants were enrolled for
1 yr spanning all 4 seasons, with 48-62% delivered from June
through November (Table 1). 
The mean 25OHD3 level was 24.5±10.7 ng/mL in moth-
ers, and 17.7±7.0 ng/mL in newborns, of which 18% were
vitamin D deficient and 73.6% were insufficient. There were
no statistically significant differences among our 3 study groups
in laboratory data at birth as well (Table 2). 
Vitamin D status and the effect of vitamin D 
supplementation in breast-fed infants at 6 months of age
Number of study infants at 6 months were 25, 28, and 21
84 M-J. Kim, B. Na, S.-J. No, et al.in group A, B, and S, respectively. The mean age was 179±
12.0 days, and there were no differences among 3 groups in
infants’ age, sex, and the other anthropometric data (Table 3). 
The mean 25OHD3 levels of infants in group A, B, and S
were 44.0±11.6, 22.5±9.24, and 34.7±12.3 ng/mL, res-
pectively, which were significantly different among 3 groups
(P<0.001, A>S>B). The prevalence of vitamin D deficiency
and insufficiency were 0% and 12%, 11% and 68%, and 0%
and 45% in group A, B, and S, respectively. Serum Ca and
AP levels were not different (P>0.05), but serum P level was
significantly different among 3 groups (P<0.001, A>S>B).
The iPTH levels in group B was 45.1±46.3 pg/mL, signifi-
cantly higher than those in group A (15.8±5.48 pg/mL)
and S (13.9±6.42 pg/mL) (P=0.001, B>A=S). Especially,
all 6 infants whose 25OHD3 levels were less than 15 ng/mL
had the iPTH levels above 40 ng/mL, presenting secondary
hyperparathyroidism due to vitamin D deficiency (Table 3,
Fig. 1A, B, 2A). 
The BMD at 6 months of age were 0.278±0.045, 0.247
±0.053 and 0.233±0.054 g/cm2 in group A, B, and S, res-
pectively. Both BMD and BMC were lower in group B and S
than those in group A (P<0.05, A>B=S) (Table 3, Fig. 1C). 
Vitamin D status of study infants and the effect of vitamin D
supplementation in breast-fed infants at 12 months of age
Number of infants participated in 12 months evaluation
were 30, 16, and 15 in group A, B and S, respectively. The
mean age was 370±13.2 days, and there were no differences
among 3 groups in infant age, sex, and other anthropometric
data (P>0.05), except the length (P=0.006, A>B, Table 4). 
The 25OHD3 levels of infants in group A, B, and S were
48.8±9.74, 33.2±7.89 and 42.8±9.80 ng/mL, respec-
tively, which was the lowest in group B and showed no dif-
ferences between group A and S (P<0.001, A=S>B). None
of the study infants at 12 months were vitamin D deficient,
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Values are presented as mean±standard deviation or number (percentile). 
Group A, formula-fed; Group B, breast-fed with no supplementation; Group S, breast-fed with vitamin D supplementation.
*P value by c2-test for categorical variables, ANOVA for continuous variables.
GP, gestational period; HC, head circumference; Edu, education; Jun-Nov, June through November.
Group A (n=25) Parameters Group B (n=28) Group S (n=21) P value*
Maternal characteristics
Age (yr) 32.1±3.6 30.2±5.7 31.9±4.2 0.2789
Employed (%) 12/25 (52.0) 6/28 (21.4) 8/21 (38.1) 0.0686
College-graduated (%) 18/24 (75.0) 14/26 (53.8) 14/21 (66.7) 0.4457
Neonatal characteristics
Sex (male) 13 (52.0) 18 (64.3) 13 (61.9) 0.6377
GP (days) 273±8.0 278±8.8 278±8.9 0.1438
Body weight (kg) 3.22±0.41 3.30±0.40 3.25±0.30 0.7068
Length (cm) 49.8±1.75 50.1±2.26 49.5±2.05 0.6664
HC (cm) 33.9±1.45 34.0±1.60 34.3±1.20 0.6816
Urban residency (%) 23 (92.0) 21 (75.0) 16 (76.2) 0.2293
Season (Jun-Nov) (%) 12 (48.0) 17 (60.7) 13 (61.9) 0.5525
Table 1. Comparison of baseline demographic data and lifestyle characteristics of the infants and mothers among 3 study groups at birth 
Values are presented as mean±standard deviation or percentile. 
Group A, formula-fed; Group B, breast-fed with no supplementation; Group S, breast-fed with vitamin D supplementation.
*P value by ANOVA; 
� Vitamin D deficient, insufficient, and sufficient were defined as 25OHD3 <11 ng/mL, 11-30 ng/mL, and >30 ng/mL, respectively. 
VD, serum 25-OH vitamin D3 (25OHD3); Ca, calcium; P, phophorus; AP, alkaline phosphatase; iPTH, intact parathyroid hormone.
Group A (n=25) Parameters Group B (n=28) Group S (n=21) P value*
Maternal VD (ng/mL) 24.1±10.9 24.5±12.5 24.8±8.48 0.9744
Neonatal data
VD
�(ng/mL) 17.0±7.6 18.0±10.3 18.1±5.6 0.8764
Deficient (%)  20.0 26.9 4.8 -
Insufficient (%) 72.0 61.5 90.5 -
Sufficient (%) 8.0 11.5 4.8 -
Ca (mg/dL) 9.96±0.75 9.92±0.73 10.0±0.54 0.9230
P (mg/dL) 5.22±0.63 5.37±0.62 5.43±0.81 0.5379
AP (U/L) 144±44.5 136±34.3 143±39.5 0.8229
iPTH (pg/mL) 5.69±3.82 5.46±2.82 5.65±3.73 0.9716
Table 2. Comparison of vitamin D status of the infants and mothers among 3 study groups at birth although 50% of infants in group B were vitamin D insuf-
ficient. Serum Ca and AP levels were not different among 3
groups, whereas serum P was significantly lower in group S
than in group A (P=0.009, A>S, A=B, and B=S). The iPTH
levels in group A, B, and S were 18.0±6.68, 22.8±7.04,
24.9±9.62 pg/mL, respectively. Group S showed significant-
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Fig. 2. Relationship between serum 25-OH vitamin D3 (25OHD3, VD) and parathyroid hormone (PTH=iPTH) levels at 6 months (A) and 12
months of age (B). 
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Group A (n=25) Parameters Group B (n=28) Group S (n=21) P value*
Age (days) 181±10.9 180±11.0 175±14.2 0.2077
Body weight (kg) 8.58±1.04 8.50±0.97 8.22±1.03 0.7616
Length (cm) 69.1±2.14 68.0±3.07 68.1±2.21 0.2271
HC (cm) 43.4±1.37 43.2±1.24 43.1±1.44 0.7471
VD
�(ng/mL) 44.0±11.6 22.5±9.24 34.7±12.3 <.0001, A>S>B
Deficient (%)  0 10.7 0 -
Insufficient (%) 12.0 67.9 45.0 -
Sufficient (%) 88.0 21.4 55.0 -
Ca (mg/dL) 10.4±0.39 10.3±0.42 10.4±0.21 0.2135
P (mg/dL) 6.27±0.33 5.43±0.80 5.76±0.25 <.0001, A>S>B
AP (U/L) 223±50.9 241±77.7 223±69.4 0.5449
iPTH (pg/mL) 15.8±5.48 45.1±46.3 13.9±6.42 0.0010, B>A=S
BMD (g/cm
2) 0.278±0.045 0.247±0.053 0.233±0.054 0.0144, A>B=S
BMC (g) 3.591±0.716 3.032±0.878 2.792±0.949 0.0078, A>B=S
IVD (mg/day) 10.9±2.5 0.58±0.35 5.1±0.97 <.0001, A>S>B
ICa (mg/day) 496±129 234±59 230±48 <.0001, A>B=S
IP (mg/day) 362±114 129±39 123±32 <.0001, A>B=S
UV (min/day) 34.6±40.3 36.1±35.2 68.7±101 0.1290
Table 3. Comparison of vitamin D status and its influencing factors of the infants among 3 study groups at 6 months of age 
Values are presented as mean±standard deviation or percentile. 
Group A, formula-fed; Group B, breast-fed without supplementation; Group S, breast-fed with vitamin D supplementation.
*P value by ANOVA, posthoc test with Duncan procedure; 
� Vitamin D deficient, insufficient, and sufficient were defined as 25OHD3 <11 ng/mL, 11-30
ng/mL, and >30 ng/mL, respectively. 
HC, head circumference; VD, serum 25-OH vitamin D3 (25OHD3); Ca, calcium; P, inorganic phophorus; AP, alkaline phosphatase; iPTH, intact parathy-
roid hormone; BMD, bone mineral density; BMC, bone mineral content; IVD, ICa, IP, total intake of vitamin D, Ca, P; UV: sun-light exposure time.
Fig. 1. Comparison of serum levels of 25-OH vitamin D3 (25OHD3) (A), parathyroid hormone (PTH=iPTH) (B), and bone mineral density
(BMD) (C) among 3 study groups at birth, 6, and 12 months of age (A, formula-fed; B, breast-fed without supplementation; S, breast-fed
with vitamin D supplementation).
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Cly higher iPTH than group A, although neither group A nor
group S was significantly different from group B (P=0.025,
S>A, A=B, and B=S) (Table 4, Fig. 1A, B). 
The BMDs in group A, B, and S at 12 months of age were
0.326±0.058, 0.286±0.078, and 0.282±0.037 g/cm2,
respectively, which was significantly higher in group A than
those in both group B and S (P=0.010, A>B=S). The BMC
was significantly higher in group A than in group S, but there
were no differences either between group A and B or bet-
ween group B and S (P=0.025, A>S, A=B, and B=S) (Table
4, Fig. 1C).
Dietary intake of vitamin D and sun-light exposure at 6 and
12 months of age
The mean amount of formula intake per day in group A
were 874±207, 806±208 mL/day at 6 and 12 months of
age, whereas the estimated daily amount of breast-milk in-
take in group B and S were 793±178 and 788±157 mL/
day at 6 months of age, 488±164 and 459±236 mL/day
at 12 months of age. The ages when solid food was first intro-
duced were similar among 3 groups, 5.32±1.12, 5.79±0.99,
5.76±0.83 months in group A, B, and S, respectively. 
At both 6 and 12 months of age, total intake of vitamin D
(the sum of vitamin D intake from milk, solid food and vita-
min supplementation) were the highest in group A, middle
in group S, and lowest in group B (P<0.001, A>S>B). Total
intake of Ca and P were higher in formula-fed infants than
breast-fed infants (P<0.001, A>B=S). In the mean time, aver-
age durations of sun-light exposure were similar in 3 groups
(Table 3, 4). 
DISCUSSION
In this study, serum levels of 25-OH vitamin D3 (25OH-
D3), iPTH and BMD were measured as indices for vitamin
D nutritional status (3, 12, 17). In general, vitamin D defi-
ciency in infancy and childhood presents clinical manifesta-
tions such as rickets, and vitamin D insufficiency may result in
an asymptomatic biochemical abnormality such as secondary
hyperparathyroidism (5, 13, 17, 18). We defined vitamin D
deficiency, insufficiency, and sufficiency as 25OHD3 less than
11 ng/mL, 11-30 ng/mL, and over 30 ng/mL, respectively (4,
12, 13). However, vitamin D deficient infants as defined in
our study did not show clinical symptom of rickets. Only 6
infants whose 25OHD3 levels less than 15 ng/mL showed
increased iPTH levels above 40 pg/mL, suggestive of secondary
hyperparathyroidism due to vitamin D insufficiency.
In adults, BMD correlates with the serum vitamin D lev-
els (19), whereas, in infants, it has been reported to have no
correlation with the serum vitamin D levels (20-23). Since
lumbar-spine (L2-L4) bone mineral density does not have
normal reference values for the infants less than 1 yr of age,
we simply compared BMDs among 3 study groups. 
The overall prevalence of vitamin D deficiency and insuf-
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Group A (n=30) Group B (n=16) Group S (n=15) P value*
Age (days) 371±11.2 367±16.7 371±11.9 0.5068
Body weight (kg) 10.2±1.02 9.90±4.52 9.57±0.87 0.1893
Length (cm) 77.5±1.64 75.3±2.60 76.5±2.58 0.0061, A>B
HC (cm) 46.5±1.11 46.0±1.64 46.0±0.93 0.3583
VD
�(ng/mL) 48.8±9.74 33.2±7.89 42.8±9.80 <.0001, A=S>B
Deficient (%)  0 0 0 -
Insufficient (%) 3.3 50.0 0 -
Sufficient (%) 96.7 50.0 100 -
Ca (mg/dL) 10.1±0.41 10.1±0.27 10.2±0.26 0.9838
P (mg/dL) 5.65±0.41 5.45±0.36 5.24±0.44 0.0089, A>S
AP (U/L) 209±59.7 224±37.8 243±66.5 0.1649
iPTH (pg/mL) 18.0±6.68 22.8±7.04 24.9±9.62 0.0251, S>A
BMD (gm/cm
2) 0.326±0.058 0.286±0.078 0.282±0.037 0.0097, A>B=S
BMC (gm) 4.651±0.785 4.145±1.003 4.030±0.729 0.0468, A>B
IVD (mg/day) 10.9±2.8 0.78±0.79 5.0±2.1 <.0001, A>S>B
ICa (mg/day) 768±216 237±96 254±74 <.0001, A>B=S
IP (mg/day) 594±154 233±122 314±98 <.0001, A>B=S
UV (min/day) 45.8±42.6 43.9±26.1 43.7±46.2 0.9833
Table 4. Comparison of vitamin D status and its influencing factors of the infants among 3 study groups at 12 months of age
Values are presented as mean±standard deviation or percentile. 
Group A, formula-fed; Group B, breast-fed without supplementation; Group S, breast-fed with vitamin D supplementation.
*P value by ANOVA, posthoc test with Duncan procedure; 
� Vitamin D deficient, insufficient, and sufficient were defined as 25OHD3 <11 ng/mL, 11-30
ng/mL, and >30 ng/mL, respectively. 
HC, head circumference; VD, serum 25-OH vitamin D3 (25OHD3); Ca, calcium; P, inorganic phophorus; AP, alkaline phosphatase; iPTH, intact parathy-
roid hormone; BMD, bone mineral density; BMC, bone mineral content; IVD, ICa, IP, total intake of vitamin D, Ca, P; UV: sun-light exposure time.
Parametersficiency in our study were 18% and 74% at birth, 4% and
43% at 6 months, and 0% and 15% at 12 months of age.
The prevalence of vitamin D deficiency in our study is lower
than the data reported by Challa et al. (56-91% at birth and
21-30% at 6 months), but similar to the data by Weiler et al.
(36% at birth by using cord blood levels of vitamin D less
than 11 ng/mL) (20, 24). 
Serum vitamin D level was determined by 2 major factors,
i.e., the dietary intake and production in the skin when ex-
posed to the sun (ultraviolet B irradiation, UVB) (1). Healthy
term infants are born with the storage of vitamin D enough
for next couple of months, and the half-life of serum vitamin
D is 12-20 days. Infant formula has been fortified with suffi-
cient amount of vitamin D (>400 IU/L), whereas breast milk
contain only 12-60 IU/L of vitamin D which is much less than
the required maintenance amount (200 IU/day) as recom-
mended by National Academy of Science (NAS) (25, 26). On
top of that, dermal conversion is seasonally unreliable source
of vitamin D and may not compensate for low nutritional
intake, particularly in infants whose skin exposure to sunlight
is limited (27). Therefore, exclusively breast-fed infants are
at high risk of vitamin D deficiency and insufficiency. Actu-
ally, the breast-fed infants showed significantly lower vitamin
D status and bone mineralization than the formula-fed infants,
as revealed in this study.
Measures to prevent vitamin D deficiency include increas-
ed skin exposure to sunlight, increased fortification of food
items with vitamin D, and vitamin D supplementation (13).
In our study, we supplemented breast-fed infants with 200
IU/day of vitamin D from 2 months of age as recommended
by American Academy of Pediatrics (AAP) in 2003 in order
to evaluate the efficacy of vitamin D supplementation. We
compared their vitamin D status and BMD with those of 2
control groups, one with breast-fed without supplementation
and the other with formula-fed at 6 and 12 months of age.
Our results showed that vitamin D supplementation (200
IU/day) in breast-fed infants increased serum 25-OH vita-
min D3, but did not increase bone mineral density. As a mat-
ter of fact, BMD and BMC were lower in breast-fed infants
than in formula-fed infants, regardless of vitamin D supple-
mentation. As vitamin D level increased at 6 months, iPTH
in supplemented group was significantly lower than in breast-
fed control. But at 12 months of age, unlike our expectation,
iPTH in supplemented group became rather higher, yet of
no significant difference, despite higher vitamin D level as
compared with breast-fed control.
Season, residence, and sun-light exposure were compared
in order to evaluate the factors on vitamin D status in this
study, and there were no differences among 3 study groups.
On the contrary, dietary intake of vitamin D, Ca, and P at 6
and 12 months were significantly different among 3 groups.
According to our survey data, daily intake of these nutrients
in all breast-fed infants, regardless of vitamin supplementa-
tion, were lower than those recommended for 5-11 month-
old infants in the 7th Korean Recommended Dietary Allo-
wances (10 mg/day of vitamin D, 300 mg/day of calcium, and
300 mg/ day of phosphorus). 
Based on our results, it was supposed that 200 IU/day of
vitamin D supplementation in breast-fed infants did increase
serum 25-OH vitamin D3, but did not increase BMD, and
did not fully correct iPTH at 12 months. Regarding these
unexpected results in our study, we speculated firstly that
200 IU/day of vitamin D supplementation in AAP recom-
mendation (2003) might not be enough to correct the vita-
min D insufficiency in late infancy. Since some researchers
have suggested 400-800 IU/day of vitamin D intake for the
prevention of vitamin D deficiency, further studies are war-
ranted to examine dose-responsive relationship of vitamin D
supplementation (1, 9, 28). 
Secondly, the amount of calcium intake should be consid-
ered. BMD depends mainly on the amount of total body cal-
cium. Therefore, an increase in calcium intake alone can en-
hance bone mineralization and effectively suppress the sec-
retion of iPTH (5, 13). It is plausible that the difference in
BMD and iPTH between the breast-fed and the formula-fed
group might result from a large amount of calcium intake in
formula-fed infants, independent of vitamin D. In addition,
1,25(OH)2D could mobilize calcium by increasing bone re-
sorption of osteoclasts if the calcium intake is very low (1, 5).
The unexpected result of iPTH in supplemented group at 12
months might also be caused by a relative excess of vitamin
D to low Ca, P intake in breast-fed infants (29). Therefore, a
clinical trial of co-supplementation of vitamin D with calci-
um would be considered to elucidate this possibility. 
Lastly, the other nutrients such as iron (10 mg/mL) and flu-
oride (0.25 mg/mL) contained in our multivitamin prepara-
tion for vitamin D source should be elucidated, because those
nutrients could influence vitamin D status and bone miner-
alization. Currently there is no commercially available prepa-
ration of vitamin D alone. A preparation of vitamin D alone
needs to be developed and used in future study to exclude this
problem. 
In conclusion, vitamin D deficiency or insufficiency was
relatively common in Korean infants. Especially, breast-fed
infants showed lower vitamin D status and bone mineraliza-
tion than formula-fed infants. Vitamin D supplementation
(200 IU/day) in breast-fed infants increased serum 25-OH
vitamin D3, but did not increase bone mineral density. 
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